On September 29, 2023, the FDA updated its list of bulk drug substances used in compounding pharmacies
Cat #: BEK-2211-2P, Biosensis Pty Ltd., SA, Australia), ChemKine TM BDNF Sandwich ELISA (Cat #: CYT306) and Milliplex Map Human Pituitary Magnetic Bead Panel 2 - Endocrine Multiplex Assay, based on Luminex /xMAP technology (Cat #: HPTP2MAG-66K, both from EMD Millipore Corporation, Billerica, MA, USA), BDNF Emax Immuno-Assay System (Cat #: G7610, Promega Corporation, Madison, WI, USA), Quantikine human BDNF Immunoassay (Cat #: DBD00, R&D Systems, Inc., Minneapolis, MN, USA)
*Correspondence: Daoyu Guo, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
The balance between ROS generation and activation of endogenous antioxidants is crucial for cells undergoing adipogenesis [87] ( Figure 2 )
Direct human use, including taking orally and injection and clinical use are forbidden.
